CLLS
Cellectis

2,608
Mkt Cap
$485.57M
Volume
73,552.00
52W High
$5.48
52W Low
$1.10
PE Ratio
-14.52
CLLS Fundamentals
Price
$4.84
Prev Close
$4.78
Open
$4.73
50D MA
$4.24
Beta
1.16
Avg. Volume
132,065.26
EPS (Annual)
-$0.4052
P/B
4.83
Rev/Employee
$186,629.20
Loading...
Loading...
News
all
press releases
Allogene Arbitration Victory Pressures Cellectis Shares Tuesday
Cellectis shares fell after Allogene cited a favorable arbitration ruling confirming control of cema-cel and outlining key CAR-T milestones.read more...
Benzinga·16d ago
News Placeholder
More News
News Placeholder
Cellectis (NASDAQ:CLLS) Share Price Crosses Above Fifty Day Moving Average - Here's Why
Cellectis (NASDAQ:CLLS) Stock Passes Above Fifty Day Moving Average - Should You Sell...
MarketBeat·1mo ago
News Placeholder
Why Cellectis Stock Is Trading Higher Today
Cellectis reports strong Nature Communications data showing CssDNA boosts non-viral gene insertion efficiency and supports long-term therapeutic potential.read more...
Benzinga·1mo ago
News Placeholder
Cellectis (NASDAQ:CLLS) Shares Cross Above Fifty Day Moving Average - Should You Sell?
Cellectis (NASDAQ:CLLS) Stock Crosses Above 50 Day Moving Average - Here's Why...
MarketBeat·1mo ago
News Placeholder
Cellectis (NASDAQ:CLLS) Posts Earnings Results, Beats Estimates By $0.11 EPS
Cellectis (NASDAQ:CLLS - Get Free Report) posted its quarterly earnings data on Friday. The biotechnology company reported $0.01 earnings per share (EPS) for the quarter, beating analysts' consensus...
MarketBeat·2mo ago
News Placeholder
Cellectis Earnings Preview
read more...
Benzinga·2mo ago
News Placeholder
This Penny Stock Has 270% Upside Potential in 2025. Is It a Buy Now?
Shares of this biotech company have had a rough ride in 2024, but analysts are feeling good about its future.
barchart.com·1y ago
<
...
1
>

Latest CLLS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.